Clinical Trial Update: Thrombolysis Treated With TNK-tPA in Acute Ischemic Stroke Patients （3T Stroke-II） [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update evaluating thrombolysis with TNK-tPA in patients with acute ischemic stroke (3T Stroke-II).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• TNK-tPA (tenecteplase)

Snippet

Sponsor: Beijing Tiantan Hospital | Conditions: Acute Ischemic Stroke | Phase 2 | Status: UNKNOWN